CMP (Civil Monetary Penalty)

CMP stands for Civil Monetary Penalty—a financial penalty that can be imposed on drug manufacturers who knowingly overcharge covered entities above the 340B ceiling price.

CMPs are administered by the HHS Office of Inspector General (OIG).

CMPs in the 340B context are primarily directed at manufacturers for overcharging. Covered entities can face civil penalties under separate provisions for knowing violations of the diversion prohibition.